Back to ELVN
Bellevue Group AG ELVN Position History
Enliven Therapeutics, Inc. • Healthcare
Quarters held
3
Latest value
$67.3M
Q3 2026
Peak value
$91M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $91M |
| Q2 2026 | $75.6M |
| Q3 2026 | $67.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $67.3M | 1.47M | — | — |
| Q2 2026 | $75.6M | 1.49M | — | — |
| Q1 2026 | $91M | 2.32M | — | — |
Other funds holding ELVN
$449.6M
$394.2M
$343.9M
$326.4M
$312M
$310.6M
$294.5M
$261.1M